The impact of vitamin D receptor genotype on the management of anemia in hemodialysis patients

American Journal of Kidney Diseases

Volumn 40, Issue 4, 2002, Pages 816-823

  Ertürk, Sehsuvar ^a   Kutlay, Sim ^a   Karabulut, Halil G ^a   Keven, Kenan ^a   Nergizoglu, Gökhan ^a   Ates, Kenan ^a   Bokesoy, Isik ^a   Duman, Neval ^a  

^a ANKARA UNIVERSITY   (Turkey)

Author keywords

Anemia; BsmI polymorphism; End stage renal disease (ESRD); Erythropoietin (EPO); Hemodialysis (HD); Inflammation; Vitamin D receptor (VDR) gene

Indexed keywords

CALCITRIOL; ERYTHROPOIETIN; PROTEIN; PROTEIN BSML; UNCLASSIFIED DRUG; VITAMIN D RECEPTOR;

ADULT; ALBUMIN BLOOD LEVEL; ANEMIA; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENOTYPE; HEMATOCRIT; HEMODIALYSIS; HEMOGLOBIN DETERMINATION; HUMAN; KIDNEY FAILURE; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE;

EID: 0036789059     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/ajkd.2002.35694     Document Type: Article

References (31)

1. Collins AJ, Ma JZ, Ebben J: Impact of hematocrit on morbidity and mortality. Semin Nephrol 20:345-349, 2000
2. Esbach JW, Downing MR, Egrie JC, Browne JK, Adamson JW: US multicenter clinical trial with recombinant human erythropoietin. Contrib Nephrol 76:160-165, 1989
3. National Kidney Foundation: DOQI Clinical Practice Guidelines for the Treatment of Anemia of Chronic Renal Failure. Am J Kidney Dis 30:S192-S240, 1997 (suppl 3)
4. Working Party for European Best Practice Guidelines for the Management of Anemia in Patients With Chronic Renal Failure: European best practice guidelines for the management of anaemia in patients with chronic renal failure. Nephrol Dial Transplant 14:S1-S50, 1999 (suppl 5)
5. Macdougall IC: Poor response to erythropoietin: Practical guideline on investigation and management. Nephrol Dial Transplant 10:607-614, 1995
6. Drüeke TB: R-HuEpo hyporesponsiveness - Who and why? Nephrol Dial Transplant 10:S62-S68, 1995 (suppl 2)
7. 3 and retinoic acid on normal human pluripotent (CFU-mix), erythroid (BFU-E), and myeloid (CFU-C) progenitor cell growth and differentiation patterns. Exp Hematol 14:60-65, 1986
8. 3 of chemically induced erythroid differentiation of K562 leukemia cells. Blood 77:1452-1461, 1991
9. Albitar S, Genin R, Fen-Chong M, Serveaux MO, Schohn D, Chuet C: High-dose alfacalcidol improves anaemia in patients on haemodialysis. Nephrol Dial Transplant 12:514-518, 1997
10. Goicoechea M, Vazquez MI, Ruiz MA, Gomez-Campdera F, Perez-Garcia R, Valderrabano F: Intravenous calcitriol improves anaemia and reduces the need for erythropoietin in haemodialysis patients. Nephron 78:23-27, 1998
11. Glorieux G, Vanholder R: Blunted response to vitamin D in uremia. Kidney Int 59:S182-S185, 2001 (suppl 78)
12. Taglibue J, Farina M, Imbasciati E, Vergani C, Annoni G: BsmI polymorphism of the vitamin D receptor gene in hyperparathyroid or hypoparathyroid dialysis patients. Am J Clin Pathol 112:366-370, 1999
13. Marco MP, Martinez I, Amoedo ML, et al: Vitamin D receptor genotype influences parathyroid hormone and calcitriol levels in predialysis patients. Kidney Int 56:1349-1353, 1999
14. Marco MP, Craver L, Betriu A, Fibla J, Fernandez E: Influence of vitamin D receptor gene polymorphism on mortality risk in hemodialysis patients. Am J Kidney Dis 38:965-974, 2001
15. Depner TA: Prescribing Hemodialysis: A Guide to Urea Modeling. Boston, MA, Kluwer, 1991, pp 65-89
16. Sambrook J, Fritsch EF, Maniatis T: Molecular Cloning: A Laboratory Manual. New York, NY, Cold Spring Harbor Laboratory, 1982, pp 458
17. Morrison NA, Cheng JQ, Tokita A, et al: Prediction of bone density from vitamin D receptor alleles. Nature 367:284-287, 1994
18. Charles G, Lundin AP III, Delano BG, Brown C, Friedman EA: Absence of anemia in maintenance hemodialysis. Int J Artif Organs 4:277-279, 1981
19. Fraser DR: Vitamin D. Lancet 345:104-107, 1995
20. 3. Immunology 72:61-64, 1991
21. Goicoechea M, Martin J, De Sequera P, et al: Role of cytokines in the response to erythropoietin in hemodialysis patients. Kidney Int 54:1337-1343, 1998
22. 3 on human bone marrow osteoclastogenesis and myelopoiesis. J Cell Biochem 72:387-395, 1999
23. Panichi V, De Pietro S, Andreini B, et al: Calcitriol modulates in vivo and in vitro cytokine production: A role for intracellular calcium. Kidney Int 54:1463-1469, 1998
24. 3 in human macrophages from CAPD patients. Kidney Int 59:69-75, 2001
25. Gunnell J, Yeun JY, Depner TA, Kaysen GA: Acute-phase response predicts erythropoietin resistance in hemodialysis and peritoneal dialysis patients. Am J Kidney Dis 33:63-72, 1999
26. Madore F, Lowrie EG, Brugnara C, et al: Anemia in hemodialysis patients: Variables affecting this outcome predictor. J Am Soc Nephrol 8:1921-1929, 1997
27. Ifudu O, Feldman J, Friedman EA: The intensity of hemodialysis and response to erythropoietin in patients with end-stage renal disease. N Engl J Med 334:420-425, 1996
28. Barany P, Divino Filho JC, Bergstrom J: High C-reactive protein is a strong predictor of resistance to erythropoietin in hemodialysis patients. Am J Kidney Dis 29:565-568, 1997
29. Leavey SF, Strawderman RL, Young EW, et al: Cross-sectional and longitudinal predictors of serum albumin in hemodialysis patients. Kidney Int 58:2119-2128, 2000
30. Dusso A, Brown A, Slatopolsky E: Extrarenal production of calcitriol. Semin Nephrol 14:144-155, 1994
31. Fernandez E, Fibla J, Betriu A, Piulats JM, Almirall J, Montoliu J: Association between vitamin D receptor gene polymorphism and relative hypoparathyroidism in patients with chronic renal failure. J Am Soc Nephrol 8:1546-1552, 1997